Recurium Equity, Llc - Net Worth and Insider Trading
Recurium Equity, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Recurium Equity, Llc owns 1 companies in total, including Zentalis Pharmaceuticals Inc (ZNTL) .
Click here to see the complete history of Recurium Equity, Llc’s form 4 insider trades.
Insider Ownership Summary of Recurium Equity, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals Inc | 2020-04-03 | 10 percent owner |
Recurium Equity, Llc Trading Performance
Recurium Equity, Llc Ownership Network
Recurium Equity, Llc Owned Company Details
What does Zentalis Pharmaceuticals Inc do?
Who are the key executives at Zentalis Pharmaceuticals Inc?
Recurium Equity, Llc is the 10 percent owner of Zentalis Pharmaceuticals Inc. Other key executives at Zentalis Pharmaceuticals Inc include Chief Financial Officer Melissa B, Epperly , General Counsel Andrea Paul , and Chief Medical Officer Carrie Brownstein .
Zentalis Pharmaceuticals Inc (ZNTL) Insider Trades Summary
Over the past 18 months, Recurium Equity, Llc made no insider transaction in Zentalis Pharmaceuticals Inc (ZNTL). Other recent insider transactions involving Zentalis Pharmaceuticals Inc (ZNTL) include a net sale of 50,090 shares made by Cam Gallagher , a net sale of 16,724 shares made by Melissa B, Epperly , and a net sale of 86,068 shares made by Kevin D. Bunker .
In summary, during the past 3 months, insiders sold 0 shares of Zentalis Pharmaceuticals Inc (ZNTL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 176,761 shares of Zentalis Pharmaceuticals Inc (ZNTL) were sold and 22,000 shares were bought by its insiders, resulting in a net sale of 154,761 shares.
Zentalis Pharmaceuticals Inc (ZNTL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zentalis Pharmaceuticals Inc Insider Transactions
Recurium Equity, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Recurium Equity, Llc. You might contact Recurium Equity, Llc via mailing address: C/o Zentalis Pharmaceuticals, Llc, 530 Seventh Avenue, Suite 2201, New York Ny 10018.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
